Clinical and morphological characteristics of sporadic genetically determined pancreatitis as compared to idiopathic pancreatitis: Higher risk of pancreatic cancer in CFTR variants

Digestion

Volumn 87, Issue 4, 2013, Pages 229-239

  Hamoir, Coralie ^a   Pepermans, Xavier ^b   Piessevaux, Hubert ^a   Jouret Mourin, Anne ^c   Weynand, Birgit ^c   Habyalimana, Jean Baptiste ^a   Leal, Teresinha ^b   Geubel, André ^a   Gigot, Jean François ^a   Deprez, Pierre H ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Center for Human Genetics   (Belgium)

^c Pathology Department   (Belgium)

Author keywords

CFTR; Pancreas cancer; Pancreatitis; PRSS1; SPINK1

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; PRSS1 PROTEIN; SERINE PROTEASE INHIBITOR KAZAL TYPE 1; SERINE PROTEINASE INHIBITOR; TRYPSINOGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; CHILD; CHRONIC PANCREATITIS; CLINICAL FEATURE; CONTROLLED STUDY; ENDOSCOPIC SPHINCTEROTOMY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GASTROSTOMY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IDIOPATHIC PANCREATITIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PANCREAS BIOPSY; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PANCREATITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SMOKING; SPORADIC GENETICALLY DETERMINED PANCREATITIS; STANDARDIZED INCIDENCE RATIO; ACUTE PANCREATITIS; CANCER DIAGNOSIS; CANCER SURVIVAL; CHOLESTASIS; CONFIDENCE INTERVAL; DUODENUM STENOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FISTULA; GENETIC SCREENING; MORPHOLOGICAL TRAIT; PANCREAS ADENOCARCINOMA; PANCREAS DIVISUM; PORTAL VEIN THROMBOSIS; STONE FORMATION; VEIN THROMBOSIS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-FREE SURVIVAL; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; RECURRENCE; TRYPSIN; YOUNG ADULT;

EID: 84878733660     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000348439     Document Type: Article

References (53)

1. Whitcomb DC: Value of genetic testing in the management of pancreatitis. Gut 2004; 53: 1710-1717 (Pubitemid 39434119)
2. DiMagno MJ, DiMagno EP: Chronic pancreatitis. Curr Opin Gastroenterol 2011; 27: 452-459
3. Drenth JP, te Morsche R, Jansen JB: Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 2002; 50: 687-692 (Pubitemid 34407498)
4. Witt H: Gene mutations in children with chronic pancreatitis. Pancreatology 2001; 1: 432-438 (Pubitemid 33681743)
5. Keiles S, Kammesheidt A: Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas 2006; 33: 221-227 (Pubitemid 44470135)
6. Pelletier AL, Bienvenu T, Rebours V, et al: CFTR gene mutation in patients with apparently idiopathic pancreatitis: lack of phenotype- genotype correlation. Pancreatology 2010; 10: 158-164
7. Whitcomb DC, Gorry MC, Preston RA, et al: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-145 (Pubitemid 26338792)
8. Keim V: Genetics of pancreatitis. Scand J Surg 2005; 94: 103-107 (Pubitemid 41169983)
9. Tzetis M, Kaliakatsos M, Fotoulaki M, et al: Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis. Clin Genet 2007; 71: 451-457 (Pubitemid 46730655)
10. Derikx MH, Drenth JP: Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis. Best Pract Res Clin Gastroenterol 2010; 24: 251-270
11. Teich N, Mossner J: Hereditary chronic pancreatitis. Best Pract Res Clin Gastroenterol 2008; 22: 115-130
12. Chen JM, Ferec C: Molecular basis of hereditary pancreatitis. Eur J Hum Genet 2000; 8: 473-479 (Pubitemid 30447118)
13. Applebaum-Shapiro SE, Finch R, Pfutzer RH, et al: Hereditary pancreatitis in North America: The Pittsburgh-Midwest Multi-Center Pancreatic Study Group Study. Pancreatology 2001; 1: 439-443 (Pubitemid 33681744)
14. Raty S, Piironen A, Babu M, et al: Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis. Scand J Gastroenterol 2007; 42: 1000-1005 (Pubitemid 47037129)
15. O'Reilly DA, Yang BM, Creighton JE, Demaine AG, Kingsnorth AN: Mutations of the cationic trypsinogen gene in hereditary and non-hereditary pancreatitis. Digestion 2001; 64: 54-60 (Pubitemid 32830552)
16. Masson E, Le Marechal C, Delcenserie R, Chen JM, Ferec C: Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation. Hum Genet 2008; 123: 521-529
17. Masson E, Le Marechal C, Chandak GR, Lamoril J, Bezieau S, Mahurkar S, Bhaskar S, Reddy DN, Chen JM, Ferec C: Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. Clin Gastroenterol Hepatol 2008; 6: 82-88
18. Le Marechal C, Masson E, Chen JM, et al: Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet 2006; 38: 1372-1374 (Pubitemid 44837557)
19. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339: 645-652 (Pubitemid 28402088)
20. Cohn JA, Friedman KJ, Noone PG, et al: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998; 339: 653-658 (Pubitemid 28402089)
21. Pfutzer RH, Barmada MM, Brunskill AP, et al: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119: 615-623
22. Witt H, Luck W, Hennies HC, et al: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25: 213-216 (Pubitemid 30394996)
23. Kume K, Masamune A, Mizutamari H, et al: Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis. Pancreatology 2005; 5: 354-360 (Pubitemid 41160272)
24. Lempinen M, Paju A, Kemppainen E, et al: Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland. Scand J Gastroenterol 2005; 40: 225-230 (Pubitemid 40189003)
25. Masson E, Le Marechal C, Levy P, et al: Coinheritance of a novel deletion of the entire SPINK1 gene with a CFTR missense mutation (L997F) in a family with chronic pancreatitis. Mol Genet Metab 2007; 92: 168-175 (Pubitemid 47361896)
26. Chandak GR, Idris MM, Reddy DN, et al: Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis. Gut 2004; 53: 723-728 (Pubitemid 38561452)
27. Midha S, Khajuria R, Shastri S, Kabra M, Garg PK: Idiopathic chronic pancreatitis in India: phenotypic characterisation and strong genetic susceptibility due to SPINK1 and CFTR gene mutations. Gut 2010; 59: 800-807
28. Rosendahl J, Landt O, Bernadova J, et al: CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? Gut 2013; 62: 582-592
29. Rebours V, Boutron-Ruault MC, Schnee M, et al: The natural history of hereditary pancreatitis: a national series. Gut 2009; 58: 97-103
30. Joergensen MT, Brusgaard K, Cruger DG, et al: Genetic, epidemiological, and clinical aspects of hereditary pancreatitis: a populationbased cohort study in Denmark. Am J Gastroenterol 2010; 105: 1876-1883
31. Rebours V, Boutron-Ruault MC, Schnee M, et al: Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 2008; 103: 111-119
32. Keim V, Witt H, Bauer N, et al: The course of genetically determined chronic pancreatitis. JOP 2003; 4: 146-154 (Pubitemid 38963782)
33. Howes N, Lerch MM, Greenhalf W, et al: Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004; 2: 252-261 (Pubitemid 38293313)
34. Schneider A, Lohr JM, Singer MV: The MANNHEIM classification of chronic pancreatitis: introduction of a unifying classification system based on a review of previous classifications of the disease. J Gastroenterol 2007; 42: 101-119 (Pubitemid 46404214)
35. Keim V: Identification of patients with genetic risk factors of pancreatitis: impact on treatment and cancer prevention. Dig Dis 2003; 21: 346-350 (Pubitemid 38209792)
36. Wojewodka G, De Sanctis JB, Radzioch D: Ceramide in cystic fibrosis: a potential new target for therapeutic intervention. J Lipids 2011; 2011: 674968
37. Lowenfels AB, Maisonneuve P, DiMagno EP, et al: Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997; 89: 442-446 (Pubitemid 27136736)
38. Lowenfels AB, Maisonneuve P, Whitcomb DC, et al: Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001; 286: 169-170 (Pubitemid 32640846)
39. Brand R, Lerch M, Rubinstein W, et al; Participants of the Fourth International Symposium of Inherited Diseases of the Pancreas: Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007; 56: 1460-1469
40. Chu D, Kohlmann W, Adler DG: Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes. JOP 2010; 11: 203-212
41. Whitcomb DC: Inflammation and cancer. V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 2004; 287:G315-G319 (Pubitemid 38955250)
42. McWilliams RR, Petersen GM, Rabe KG, et al: Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma. Cancer 2010; 116: 203-209
43. Malats N, Casals T, Porta M, et al: Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. Gut 2001; 48: 70-74 (Pubitemid 32042644)
44. Maisonneuve P, Marshall BC, Lowenfels AB: Risk of pancreatic cancer in patients with cystic fibrosis. Gut 2007; 56: 1327-1328 (Pubitemid 47300446)
45. Hunter MJ, Treharne KJ, Winter AK, Cassidy DM, Land S, Mehta A: Expression of wildtype CFTR suppresses NF-kappaB-driven inflammatory signalling. PLoS One 2010; 5:e11598
46. Xie C, Jiang XH, Zhang JT, et al: CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene 2012, Epub ahead of print.
47. Lacobuzio-Donahue C: Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project. Gut 2012; 61: 1085-1094
48. Neglia JP, FitzSimmons SC, Maisonneuve P, Schoni MH, Schoni-Affolter F, Corey M, Lowenfels AB: The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995; 332: 494-499
49. Lankisch PG, Assmus C, Maisonneuve P, et al: Epidemiology of pancreatic diseases in Luneburg County. A study in a defined German population. Pancreatology 2002; 2: 469-477 (Pubitemid 36151343)
50. Cohn JA: Reduced CFTR function and the pathobiology of idiopathic pancreatitis. J Clin Gastroenterol 2005; 39:S70-S77 (Pubitemid 40397019)
51. Rosendahl J, Witt H, Szmola R, et al: Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008; 40: 78-82
52. Paliwal S, Bhaskar S, Mani KR, et al: Comprehensive screening of chymotrypsin C (CTRC) gene in tropical calcific pancreatitis identifies novel variants. Gut 2012, E-pub ahead of print
53. Chen JM, Ferec C: Genetics and pathogenesis of chronic pancreatitis: the 2012 update. Clin Res Hepatol Gastroenterol 2012; 36: 334-340.